|
|
||||||||
AJP - Lung Cellular and Molecular Physiology, Vol 266, Issue 2 148-L155, Copyright © 1994 by American Physiological Society
ARTICLES |
H. Blau, S. Riklis, V. Kravtsov and M. Kalina
Department of Histology and Cell Biology, Sackler School of Medicine, Tel Aviv University, Israel.
Cultured alveolar type II cells and pulmonary epithelial (PE) cells in long-term culture were found to secrete colony-stimulating factors (CSF) into the medium in similar fashion to alveolar macrophages. CSF activity was determined by using the in vitro assay for myeloid progenitor cells [colony-forming units in culture (CFU-C)]. Both lipopolisaccharide (LPS) and interleukin-1 alpha (IL-1 alpha) were found to upregulate the secretion 6.5- to 8-fold from alveolar type II cells and macrophages. However, no stimulatory effect of these factors was observed in PE cells that release CSF into the medium constitutively, possibly due to the conditions of long-term culture. The CSF activity was partially neutralized (70% inhibition) by antibodies against murine granulocyte/macrophage (GM)-CSF and IL-3, thus indicating the presence of both GM-CSF and IL-3-like factors in the CSF. However, the presence of other cytokines in the CSF is highly probable. Surfactant-associated protein A (SP-A), which is known to play a central role in surfactant homeostasis and function, was also found to upregulate secretion of CSF (at concentrations of 0.1-5 micrograms/ml) from alveolar type II cells and macrophages. Control cells such as rat peritoneal macrophages, alveolar fibroblasts, and 3T3/NIH cell line could not be elicited by SP-A to release CSF. The results are discussed in relation to the possible participation of the alveolar epithelial cells in various intercellular signaling networks. Our studies suggest that alveolar type II cells and SP-A may play an important regulatory role in the modulation of immune and inflammatory effector cells within the alveolar space.
This article has been cited by other articles:
![]() |
B. Janic, T. M. Umstead, D. S. Phelps, and J. Floros Modulatory effects of ozone on THP-1 cells in response to SP-A stimulation Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L317 - L325. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Pan, R. J. Mason, J. Y. Westcott, and J. M. Shannon Rat Alveolar Type II Cells Inhibit Lung Fibroblast Proliferation In Vitro Am. J. Respir. Cell Mol. Biol., September 1, 2001; 25(3): 353 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hawgood, J. Akiyama, C. Brown, L. Allen, G. Li, and F. R. Poulain GM-CSF mediates alveolar macrophage proliferation and type II cell hypertrophy in SP-D gene-targeted mice Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1148 - L1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. KHUBCHANDANI and J. M. SNYDER Surfactant protein A (SP-A): the alveolus and beyond FASEB J, January 1, 2001; 15(1): 59 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Borron, J. C. McIntosh, T. R. Korfhagen, J. A. Whitsett, J. Taylor, and J. R. Wright Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo Am J Physiol Lung Cell Mol Physiol, April 1, 2000; 278(4): L840 - L847. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rosseau, P. Hammerl, U. Maus, A. Gunther, W. Seeger, F. Grimminger, and J. Lohmeyer Surfactant Protein A Down-Regulates Proinflammatory Cytokine Production Evoked by Candida albicans in Human Alveolar Macrophages and Monocytes J. Immunol., October 15, 1999; 163(8): 4495 - 4502. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Miles, L. Bowman, K. M. K. Rao, J. E. Baatz, and L. Huffman Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages Am J Physiol Lung Cell Mol Physiol, January 1, 1999; 276(1): L186 - L196. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Prokhorova, N. Patel, and D. L. Laskin Regulation of alveolar macrophage and type II cell DNA synthesis: effects of ozone inhalation Am J Physiol Lung Cell Mol Physiol, December 1, 1998; 275(6): L1200 - L1207. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alberti, F. Ravenna, D. Quaglino, M. Luisetti, M. Muraca, L. Previato, G. B. Enzi, R. Bruni, and A. Baritussio In chyloptysis, SP-A affects the clearance of serum lipoproteins entering the airways Am J Physiol Lung Cell Mol Physiol, May 1, 1998; 274(5): L737 - L749. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ikegami, A. H. Jobe, J. A. H. Reed, and J. A. Whitsett Surfactant metabolic consequences of overexpression of GM-CSF in the epithelium of GM-CSF-deficient mice Am J Physiol Lung Cell Mol Physiol, October 1, 1997; 273(4): L709 - L714. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. H. Reed, W. R. Rice, Z. K. Zsengeller, S. E. Wert, G. Dranoff, and J. A. Whitsett GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice Am J Physiol Lung Cell Mol Physiol, October 1, 1997; 273(4): L715 - L725. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. DOYLE, K. G. DAVIDSON, H. A. BARR, T. E. NICHOLAS, K. PAYNE, and J. PFITZNER Quantity and Structure of Surfactant Proteins Vary Among Patients with Alveolar Proteinosis Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 658 - 664. [Abstract] [Full Text] |
||||
![]() |
P. Juvin, T. Fournier, M. Grandsaigne, J.-M. Desmonts, and M. Aubier Diesel particles increase phosphatidylcholine release through a NO pathway in alveolar type II cells Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L1075 - L1081. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |